< Back to latest news & events

Event

UPC event in Ireland: Maintaining commercial relevance of your European IP strategy with the new Unified Patent Court system

August 2022

Event date: 6th October 2022

Join HGF in association with Ibec for our networking event and panel discussion exploring the practical ramifications of the Unitary Patent and Unified Patent Court

Date

Thursday 6th October, 2022

Time

6PM

Venue

The Guinness Enterprise Centre (GEC), Dublin

About the event

The patent landscape in Europe is on the brink of the most significant change in a generation; a change that could significantly alter what is the most commercially relevant and cost-effective patent strategy for your business. We invite you to learn more about the strategic considerations and practicalities of the Unitary Patent (UP) and Unified Patent Court (UPC).

Our panellists will discuss:

  • What does this mean for Irish businesses of all sizes and across all sectors for existing European patents and for future IP strategies?
  • What are the advantages and cost benefits of the UP and UPC for Irish businesses; and
  • What steps does Ireland need to take to be able to access the benefits the UPC could bring?
Panellists
  • Naoise Gaffney, Head of Intellectual Property, GH Research and Chair of the Ibec Corporate IP Group
  • Fiona Ryan, Start Up & Entrepreneurship Lecturer, Technological University Dublin and Co-Founder of Colata
  • Joe Doyle, Intellectual Property Manager, Enterprise Ireland
  • Andrew Knox, Lecturer in Biochemistry and Principal Investigator, Technological University Dublin and Founder of MyWorkaway
  • Rachel Fetches, Partner & Head of Law, HGF
  • Marie Walsh, Patent Director, HGF
Ireland and UPC

All Irish businesses will need to make important decisions now about their European patents as the UPC will affect all granted European patents and pending European patent applications, irrespective of the status of the Irish government’s progress towards ratification of the UPC Agreement. Additionally, the European Patent office (EPO) has announced new measures for supporting users in an early uptake of the UP.

Looking forward, there is a significant opportunity for Ireland to enhance its reputation as a hub for end-to-end IP activity, including obtaining and enforcement of IP rights. An Irish Local Division of the Unified Patent Court would support the further expansion of the patent-intensive sectors across the country, creating jobs, benefitting all Irish businesses and boosting Ireland’s innovation performance.

Further, the European UPC’s Central Division must find a new location, instead of London, for the cases it will handle in the chemicals, biopharmaceuticals and medical device sectors. These industries are key contributors to the Irish economy. As an English-speaking, common law jurisdiction, with strong links to the US and the rest of the world, Ireland is well-placed as a location for the Central Division Court which would mean easier access to enforcement of IP rights for Irish-based companies in those sectors.

Latest updates

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

Often Copied, Never Equaled: When Do Everyday Items Become Subject of Copyright?

The  borderline between ‘pure’ works of art and mere utilitarian objects” –  Can iconic, yet everyday products be protected under copyright? The above question was posed by Advocate General in …

Read article

T 0883/23: Dosage claims and their entitlement to priority when only the clinical trial protocol was disclosed in the priority application

In a recently issued decision by the EPO’s Board of Appeal (BoA), the BoA held that claims directed to a combination of active pharmaceutical ingredients (APIs) at particular doses were …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details

Personal names as 'brands' in the world of fashion

Episode 1 Personal names as ‘brands’ in the world of fashion    

Read article